(Q40389343)

20 September 2017

1 reference

title

Melanoma vaccines. Current status and future prospects (English)

1 reference

20 September 2017

P Hersey

1

1 reference

20 September 2017

1 March 1994

1 reference

20 September 2017

1 reference

20 September 2017

47

1 reference

20 September 2017

373-382

1 reference

20 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199447030-00001

20 September 2017

0 references

cites work

Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?

1 reference

12 December 2020

Immunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant Melanoma

1 reference

12 December 2020

Approaches to augmenting the IgG antibody response to melanoma ganglioside vaccines

1 reference

12 December 2020

RAC Unanimously Approves Cancer Vaccine Trial

1 reference

12 December 2020

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

12 December 2020

Western blot analysis of serological responses following immunization with vaccinia viral lysates of melanoma cells

1 reference

12 December 2020

Gene therapy for cancer

1 reference

12 December 2020

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

1 reference

12 December 2020

At age 2, gene therapy enters a growth phase

1 reference

12 December 2020

Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

1 reference

12 December 2020

Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine

1 reference

12 December 2020

Inflammatory cell infiltrates in human melanoma at different stages of tumor progression

1 reference

12 December 2020

Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses

1 reference

12 December 2020

Characterization of a 90-100 kDa tumor-associated antigen in the sera of melanoma patients

1 reference

12 December 2020

Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells

1 reference

12 December 2020

Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody

1 reference

12 December 2020

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Current status and future prospects for adjuvant therapy of melanoma

1 reference

12 December 2020

Identification of human cancers deficient in antigen processing

1 reference

12 December 2020

Novel gene sequences expressed by human melanoma cells identified by molecular subtraction

1 reference

12 December 2020

High efficiency gene transfer into primary human tumor explants without cell selection.

1 reference

12 December 2020

Flying the first class flag

1 reference

12 December 2020

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

12 December 2020

Immunogenicity of melanoma-associated gangliosides in cancer patients

1 reference

12 December 2020

Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine

1 reference

12 December 2020

Teaching the immune system to fight cancer.

1 reference

12 December 2020

Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma

1 reference

12 December 2020

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

12 December 2020

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen

1 reference

12 December 2020

Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody

1 reference

12 December 2020

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases

1 reference

12 December 2020

Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma

1 reference

12 December 2020

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

1 reference

12 December 2020

Cloning and in vitro expression of a melanoma-associated antigen immunogenic in patients with melanoma

1 reference

12 December 2020

Modulation of T-cell function by gliomas

1 reference

12 December 2020

Evaluation of vaccinia viral lysates as therapeutic vaccines in the treatment of melanoma

1 reference

12 December 2020

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines

1 reference

12 December 2020

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

1 reference

12 December 2020

Gene therapy for cancer

1 reference

12 December 2020

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

1 reference

12 December 2020

Clinical trials with VMO for melanoma

1 reference

12 December 2020

Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL).

1 reference

12 December 2020

Treatment of human melanoma with a hapten-modified autologous vaccine

1 reference

12 December 2020

A molecular model of MHC class-I-restricted antigen processing

1 reference

12 December 2020

Gene therapy. A speeding ticket for NIH's controversial cancer star

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

12 December 2020

Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. III. Physicochemical properties

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Cancer dormancy: studies of the murine BCL1 lymphoma

1 reference

12 December 2020

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

1 reference

12 December 2020

Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens

1 reference

12 December 2020

A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97

1 reference

12 December 2020

Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene

1 reference

12 December 2020

ME491 melanoma-associated glycoprotein family: antigenic identity of ME491, NKI/C-3, neuroglandular antigen (NGA), and CD63 proteins

1 reference

12 December 2020

10.2165/00003495-199447030-00001

Identifiers

DOI

1 reference

PubMed ID

7514970

Dimensions Publication ID

20 September 2017

0 references

1 reference

PubMed ID

7514970